William Anderson

Genetic Testing, Privacy, and Healthcare

Genetic Testing, Privacy, and Healthcare

Tests for Genetic Diseases There are many different tests available for genetic diseases. Some people use direct-to-consumer testing to see whether they are at risk for certain genetic diseases. Genetic testing is also available through a genetic specialist or your primary care physician. In the medical setting, your doctor will first determine if you would... Read More

Building Blocks of the Genetic Code

Building Blocks of the Genetic Code

DNA: The Body’s Instruction Manual Humans and all other living things have DNA, which contains hereditary information. The information in your DNA gives your cells instructions for producing proteins. Proteins drive important body functions, like digesting food, building cells, and moving your muscles. Your DNA is the most unique and identifying factor about you—it helps... Read More

Denouncing the Misuse of Genetics

Denouncing the Misuse of Genetics

ASHG denounces the misuse of genetics to feed racist ideologies, and affirms that the research community should be clear about genetic knowledge related to ancestry and genomic diversity. Any attempt to use genetics to rank populations demonstrates a fundamental misunderstanding of genetics. Related: AJHG Perspective: ASHG Denounces Attempts to Link Genetics and Racial Supremacy (November... Read More

Protecting Genetic Privacy of Immigrant Families

Protecting Genetic Privacy of Immigrant Families

In 2018, a legislative amendment was proposed that would protect the genetic privacy of immigrant families by restricting the use of their genetic material and data to helping reunify family members. The amendment would require that government officials restrict their use of DNA analysis to when it is truly needed and ensure that biological samples... Read More

Advancing Evidence-Based Genetic Testing

Advancing Evidence-Based Genetic Testing

In 2018, the U.S. Food and Drug Administration (FDA) invited comments on its intention to exempt a list of class II devices from premarket notification requirements, including tests assessing genetic health risks. ASHG responded to this request for comment by outlining its support for regulation that brings scientifically valid, evidence-based tests to market, and expressing... Read More